Recursion Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US75629V1044

Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Christopher Gibson. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Christopher Gibson har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
US:RXRX / Recursion Pharmaceuticals, Inc. Chief Executive Officer, Director 954 229
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Christopher Gibson. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderköp RXRX / Recursion Pharmaceuticals, Inc. - Analys av kortsiktig vinst

I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i RXRX / Recursion Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
max
Pris vid
max
Max
vinst ($)
Maximal avkastning (%)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

RXRX / Recursion Pharmaceuticals, Inc. Insider Trades
Insiderförsäljning - Analys av kortsiktig förlust

I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i RXRX / Recursion Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
min
Pris vid
min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2022-03-15 RXRX Gibson Christopher 6 150 6,0825 6 150 6,0825 37 407 57 5.0400 −6 411 −17,14
2022-03-14 RXRX Gibson Christopher 230 000 6,2818 230 000 6,2818 1 444 814
2022-03-11 RXRX Gibson Christopher 100 000 6,9458 100 000 6,9458 694 580
2022-03-07 RXRX Gibson Christopher 300 000 7,2965 300 000 7,2965 2 188 950
2022-02-22 RXRX Gibson Christopher 100 000 10,2154 100 000 10,2154 1 021 540
2022-01-31 RXRX Gibson Christopher 19 858 11,7315 19 858 11,7315 232 964
2022-01-14 RXRX Gibson Christopher 254 000 13,5654 254 000 13,5654 3 445 612
2022-01-13 RXRX Gibson Christopher 78 206 14,2571 78 206 14,2571 1 114 991
2022-01-13 RXRX Gibson Christopher 8 794 14,9619 8 794 14,9619 131 575

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

RXRX / Recursion Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Christopher Gibson som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris
Transaktionsvärde Återstående
värde
2025-09-12 2025-09-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −20 000 954 229 −2,05
2025-09-12 2025-09-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −100 000 974 229 −9,31 4,71 −471 000 4 588 619
2025-09-12 2025-09-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 120 000 1 074 229 12,58
2025-08-28 2025-08-26 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −100 000 954 229 −9,49 4,84 −484 000 4 618 468
2025-08-28 2025-08-26 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100 000 1 054 229 10,48
2025-08-19 2025-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −40 390 954 229 −4,06 5,64 −227 800 5 381 852
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −17 875 0 −100,00 5,28 −94 380
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 17 875 17 875
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −100 000 0 −100,00 5,28 −528 000
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100 000 100 000
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 994 619 −1,00
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 300 1 004 619 −33,24 5,28 −2 641 584 5 304 388
2025-08-13 2025-08-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 423 666 1 504 919 39,18
2025-05-19 2025-05-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −36 197 1 081 253 −3,24 4,25 −153 837 4 595 325
2025-03-28 2025-03-27 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −138 574 1 117 450 −11,03 6,04 −836 987 6 749 398
2025-03-07 2025-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 1 256 024 −1,57 6,37 −127 400 8 000 873
2025-03-07 2025-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 1 276 024 1,59
2025-03-07 2025-03-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 1 256 024 −1,57 6,58 −131 600 8 264 638
2025-03-07 2025-03-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 1 276 024 1,59
2025-02-20 2025-02-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −17 132 1 256 024 −1,35 10,64 −182 284 13 364 095
2025-02-07 2025-02-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 1 273 156 −1,55 8,12 −162 400 10 338 027
2025-02-07 2025-02-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 1 293 156 1,57
2025-02-07 2025-02-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 1 273 156 −1,55 7,68 −153 600 9 777 838
2025-02-07 2025-02-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 1 293 156 1,57
2025-02-05 2025-02-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −5 569 1 273 156 −0,44 7,25 −40 375 9 230 381
2025-02-05 2025-02-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 16 809 1 278 725 1,33
2025-02-05 2025-02-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 525 283 1 261 916 71,31
2025-01-13 2025-01-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 736 633 −2,64 7,05 −141 000 5 193 263
2025-01-13 2025-01-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 756 633 2,72
2025-01-13 2025-01-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 736 633 −2,64 7,31 −146 200 5 384 787
2025-01-13 2025-01-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 756 633 2,72
2024-12-06 2024-12-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 736 633 −2,64 7,12 −142 400 5 244 827
2024-12-06 2024-12-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 756 633 2,72
2024-12-06 2024-12-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 736 633 −2,64 7,16 −143 200 5 274 292
2024-12-06 2024-12-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 756 633 2,72
2024-11-19 2024-11-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −26 023 736 633 −3,41 6,18 −160 692 4 548 709
2024-11-15 2024-11-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 762 656 −2,56 7,35 −147 000 5 605 522
2024-11-15 2024-11-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 782 656 2,62
2024-11-15 2024-11-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 762 656 −2,56 7,74 −154 800 5 902 957
2024-11-15 2024-11-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 782 656 2,62
2024-10-04 2024-10-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 762 656 −2,56 6,08 −121 600 4 636 948
2024-10-04 2024-10-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 782 656 2,62
2024-10-04 2024-10-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 762 656 −2,56 6,16 −123 200 4 697 961
2024-10-04 2024-10-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 782 656 2,62
2024-09-06 2024-09-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 762 656 −2,56 6,14 −122 800 4 682 708
2024-09-06 2024-09-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 782 656 2,62
2024-09-06 2024-09-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 762 656 −2,56 6,04 −120 800 4 606 442
2024-09-06 2024-09-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 782 656 2,62
2024-08-30 2024-08-30 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5 000 762 656 0,66 2,48 12 400 1 891 387
2024-08-29 2024-08-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5 000 757 656 0,66 2,48 12 400 1 878 987
2024-08-28 2024-08-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5 000 752 656 0,67 2,48 12 400 1 866 587
2024-08-27 2024-08-27 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5 000 747 656 0,67 2,48 12 400 1 854 187
2024-08-26 2024-08-26 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5 000 742 656 0,68 2,48 12 400 1 841 787
2024-08-23 2024-08-23 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise 5 000 737 656 0,68 2,48 12 400 1 829 387
2024-08-19 2024-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −26 082 732 656 −3,44 6,69 −174 489 4 901 469
2024-08-09 2024-08-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 758 738 −2,57 6,50 −130 000 4 931 797
2024-08-09 2024-08-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 778 738 2,64
2024-08-09 2024-08-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −30 000 758 738 −3,80 7,10 −213 000 5 387 040
2024-08-09 2024-08-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 30 000 788 738 3,95
2024-07-12 2024-06-05 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100 000 908 738 12,36
2024-07-12 2024-07-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −50 000 758 738 −6,18 7,47 −373 500 5 667 773
2024-07-12 2024-07-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 50 000 808 738 6,59
2024-07-12 2024-07-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −50 000 758 738 −6,18 7,48 −374 000 5 675 360
2024-07-12 2024-07-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 50 000 808 738 6,59
2024-07-12 2024-07-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −25 000 758 738 −3,19
2024-06-07 2024-06-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −50 000 708 738 −6,59 9,00 −450 000 6 378 642
2024-06-07 2024-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −50 000 758 738 −6,18 8,42 −421 000 6 388 574
2024-06-07 2024-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −25 000 808 738 −3,00
2024-06-07 2024-06-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25 000 833 738 3,09
2024-05-17 2024-05-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −26 082 808 738 −3,12 10,01 −261 081 8 095 467
2024-05-03 2024-05-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −21 296 834 820 −2,49 8,47 −180 377 7 070 925
2024-05-03 2024-05-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 21 296 856 116 2,55
2024-05-03 2024-05-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −28 704 834 820 −3,32 8,47 −243 123 7 070 925
2024-05-03 2024-05-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −50 000 863 524 −5,47 7,73 −386 500 6 675 041
2024-05-03 2024-05-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −25 000 913 524 −2,66
2024-04-05 2024-04-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −25 000 0 −100,00 9,02 −225 500
2024-04-05 2024-04-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25 000 25 000
2024-04-05 2024-04-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −40 000 938 524 −4,09 9,02 −360 800 8 465 486
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −25 000 0 −100,00 8,84 −221 000
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25 000 25 000
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −40 000 978 524 −3,93 8,84 −353 600 8 650 152
2024-04-05 2024-04-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −25 000 1 018 524 −2,40
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −25 000 0 −100,00 10,10 −252 500
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 25 000 25 000
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −40 000 1 043 524 −3,69 10,10 −404 000 10 539 592
2024-04-01 2024-03-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −25 000 1 083 524 −2,26
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 11,56 −11 562
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 0 −100,00 11,55 −231 002
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 20 000
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 000 0 −100,00 11,56 −46 259
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4 000 4 000
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −36 319 1 108 524 −3,17 11,86 −430 682 13 145 210
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 8 674 1 144 843 0,76 11,40 98 884 13 051 210
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 1 136 169 2,83 2,48 77 500 2 817 699
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 1 104 919 −0,90
2024-03-08 2024-03-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 1 114 919 0,91
2024-02-16 2024-02-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −11 148 1 104 919 −1,00 12,43 −138 570 13 734 143
2024-02-13 2024-02-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −3 233 1 116 067 −0,29 10,09 −32 621 11 261 116
2024-02-13 2024-02-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 333 449 1 119 300 42,43
2024-02-13 2024-02-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 11 148 785 851 1,44
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −48 272 774 703 −5,87 9,22 −444 981 7 141 367
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 822 975 3,95 2,48 77 500 2 040 978
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 791 725 −1,25
2024-02-09 2024-02-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 801 725 1,26
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,49 −9 494
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 0 −100,00 9,51 −190 240
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 20 000
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 000 0 −100,00 9,51 −38 029
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4 000 4 000
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −30 853 791 725 −3,75 9,49 −292 804 7 513 708
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 822 578 3,95 2,48 77 500 2 039 993
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 791 328 −1,25
2024-01-05 2024-01-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 801 328 1,26
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −59 829 791 328 −7,03 7,49 −448 394 5 930 687
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 851 157 3,81 2,48 77 500 2 110 869
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 819 907 −1,20
2023-12-08 2023-12-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 829 907 1,22
2023-11-17 2023-11-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −16 913 819 907 −2,02 7,18 −121 435 5 886 932
2023-11-17 2023-11-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 836 820 −1,18
2023-11-17 2023-11-10 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 846 820 1,20
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 5,14 −5 137
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 0 −100,00 5,11 −102 294
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 20 000
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 000 0 −100,00 5,14 −20 564
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4 000 4 000
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −37 177 836 820 −4,25 5,20 −193 306 4 351 129
2023-11-03 2023-11-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 873 997 3,71 2,48 77 500 2 167 513
2023-10-18 2023-10-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 842 747 −1,17
2023-10-18 2023-10-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 852 747 1,19
2023-10-06 2023-10-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −59 794 842 747 −6,63 7,21 −431 025 6 074 942
2023-10-06 2023-10-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 902 541 3,59 2,48 77 500 2 238 302
2023-09-19 2023-09-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 871 291 −1,13
2023-09-19 2023-09-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 881 291 1,15
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 8,84 −8 836
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 0 −100,00 8,83 −176 696
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 20 000
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 000 0 −100,00 8,83 −35 335
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4 000 4 000
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −33 765 871 291 −3,73 8,78 −296 575 7 652 984
2023-09-08 2023-09-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 905 056 3,58 2,48 77 500 2 244 539
2023-08-17 2023-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −16 913 873 806 −1,90 9,19 −155 430 8 030 277
2023-08-11 2023-08-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 890 719 −1,11
2023-08-11 2023-08-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 900 719 1,12
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 060 890 719 −0,45 13,36 −54 254 11 902 767
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −60 955 894 779 −6,38 13,02 −793 457 11 647 428
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 955 734 3,38 2,48 77 500 2 370 220
2023-08-04 2023-08-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 8 674 924 484 0,95 11,40 98 884 10 539 118
2023-07-21 2023-07-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 915 810 −1,08
2023-07-21 2023-07-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 925 810 1,09
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −13 0 −100,00 14,85 −193
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −63 13 −82,89 13,75 −867 179
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −127 76 −62,56 12,36 −1 569 939
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −561 203 −73,43 11,82 −6 634 2 400
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −236 764 −23,60 10,87 −2 565 8 305
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −550 0 −100,00 14,03 −7 716
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 693 550 −89,51 12,41 −58 255 6 827
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −10 327 5 243 −66,33 11,74 −121 282 61 575
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 430 15 570 −22,15 10,84 −48 013 168 751
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 20 000
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −127 0 −100,00 14,06 −1 786
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −850 127 −87,00 12,41 −10 546 1 576
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −2 173 977 −68,98 11,80 −25 642 11 529
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −850 3 150 −21,25 10,82 −9 198 34 085
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4 000 4 000
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −17 227 915 810 −1,85 14,34 −247 104 13 136 379
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −3 270 933 037 −0,35 12,39 −40 506 11 557 809
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −7 898 936 307 −0,84 11,80 −93 172 11 045 520
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −3 423 944 205 −0,36 10,87 −37 194 10 259 543
2023-07-14 2023-07-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 947 628 3,41 2,48 77 500 2 350 117
2023-06-16 2023-06-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 916 378 −1,08
2023-06-16 2023-06-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 10 000 926 378 1,09
2023-06-09 2023-06-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −56 436 916 378 −5,80 9,05 −510 808 8 294 229
2023-06-09 2023-06-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 972 814 3,32 2,48 77 500 2 412 579
2023-05-17 2023-05-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −11 661 941 564 −1,22 5,60 −65 302 5 272 758
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 4,92 −4 915
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 0 −100,00 4,90 −98 036
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 20 000
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 000 0 −100,00 4,91 −19 623
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4 000 4 000
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −33 073 953 225 −3,35 4,71 −155 761 4 489 308
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 986 298 3,27 2,48 77 500 2 446 019
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −1 338 955 048 −0,14
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 338 956 386 0,14
2023-05-05 2023-05-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −8 662 955 048 −0,90
2023-05-05 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 963 710 −0,31
2023-05-05 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 966 710 0,31
2023-05-05 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 963 710 −0,31
2023-05-05 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 966 710 0,31
2023-05-05 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 963 710 −0,31
2023-05-05 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 966 710 0,31
2023-04-28 2022-12-14 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 582 805 −0,51
2023-04-28 2022-12-14 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 585 805 0,51
2023-04-28 2022-11-16 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 582 805 −0,51
2023-04-28 2022-11-16 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 585 805 0,51
2023-04-28 2022-10-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 582 805 −0,51
2023-04-28 2022-10-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 585 805 0,51
2023-04-28 2022-09-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 582 805 −0,51
2023-04-28 2022-09-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 585 805 0,51
2023-04-28 2022-08-17 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 582 805 −0,51
2023-04-28 2022-08-17 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 585 805 0,51
2023-04-28 2022-07-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 582 805 −0,51
2023-04-28 2022-07-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 585 805 0,51
2023-04-28 2022-06-21 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 582 805 −0,51
2023-04-28 2022-06-21 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 585 805 0,51
2023-04-28 2022-05-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −12 000 582 805 −2,02
2023-04-28 2022-05-19 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12 000 594 805 2,06
2023-04-28 2022-05-12 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −12 000 582 805 −2,02
2023-04-28 2022-05-12 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12 000 594 805 2,06
2023-04-28 2022-04-25 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −12 000 582 805 −2,02
2023-04-28 2022-04-25 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12 000 594 805 2,06
2023-04-28 2022-01-05 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 582 805 −3,08 7,39 −136 669 4 305 472
2023-04-28 2022-01-05 4/A RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 601 305 3,17
2023-04-07 2023-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −40 000 906 710 −4,23 6,64 −265 672 6 022 186
2023-04-07 2023-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −13 327 946 710 −1,39 6,46 −86 038 6 111 865
2023-04-07 2023-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 960 037 3,36 2,48 77 500 2 380 892
2023-04-07 2023-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 928 787 −1,07
2023-03-15 2023-03-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 938 787 −0,32
2023-03-15 2023-03-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 3 000 941 787 0,32
2023-03-10 2023-03-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −15 000 938 787 −1,57 7,77 −116 620 7 298 787
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 8,09 −8 087
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −20 000 0 −100,00 8,10 −161 900
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 20 000 20 000
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −4 000 0 −100,00 8,09 −32 362
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 4 000 4 000
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −10 000 953 787 −1,04
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −70 890 963 787 −6,85 8,10 −573 925 7 802 820
2023-03-10 2023-03-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 93 750 1 034 677 9,96 2,48 232 500 2 565 999
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,91 −7 909
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,91 −7 906
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 7,90 −3 952
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 940 927 −1,93 7,92 −146 502 7 451 201
2023-03-06 2023-03-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 956 427 1,97
2023-02-17 2023-02-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −1 346 940 927 −0,14 8,44 −11 360 7 941 424
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,20 −9 202
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,21 −9 208
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 9,21 −4 604
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 942 273 −1,93 9,22 −170 548 8 686 626
2023-02-03 2023-02-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 960 773 1,96
2023-02-03 2023-02-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −1 382 942 273 −0,15 8,55 −11 816 8 056 434
2023-02-03 2023-02-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 11 050 943 655 1,18
2023-02-03 2023-02-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 406 800 932 605 77,37
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,38 −7 382
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,39 −7 391
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 7,38 −3 689
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 525 805 −3,40 7,39 −136 669 3 884 384
2023-01-06 2023-01-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 544 305 3,52
2023-01-06 2022-12-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 525 805 −0,57
2023-01-06 2022-11-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 528 805 −0,56
2023-01-06 2022-10-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 531 805 −0,56
2023-01-06 2022-09-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 534 805 −0,56
2023-01-06 2022-08-17 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 537 805 −0,55
2023-01-06 2022-07-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 540 805 −0,55
2023-01-06 2022-06-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −3 000 543 805 −0,55
2023-01-06 2022-05-19 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −12 000 546 805 −2,15
2023-01-06 2022-05-12 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −12 000 558 805 −2,10
2023-01-06 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −12 000 570 805 −2,06
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,28 −9 277
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,28 −9 277
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 9,26 −4 632
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 582 805 −3,08 9,28 −171 615 5 406 391
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 601 305 3,17
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 710 582 805 −3,11 8,77 −164 145 5 113 007
2022-12-02 2022-12-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 601 515 5,48 2,48 77 500 1 491 757
2022-11-17 2022-11-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −5 751 570 265 −1,00 11,86 −68 207 6 763 343
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 10,10 −10 099
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 10,10 −10 098
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 10,11 −5 055
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 576 016 −3,11 10,11 −187 037 5 823 579
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 594 516 3,21
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 193 576 016 −3,06 9,89 −179 911 5 696 222
2022-11-04 2022-11-03 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 594 209 5,55 2,48 77 500 1 473 638
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 11,64 −11 641
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 11,64 −11 643
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 11,64 −5 821
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 562 959 −3,18 11,65 −215 551 6 559 260
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 581 459 3,29
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −17 553 562 959 −3,02 11,50 −201 917 6 475 886
2022-10-07 2022-10-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 580 512 5,69 2,48 77 500 1 439 670
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 10,50 −10 504
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 10,50 −10 502
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 10,50 −5 249
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 549 262 −3,26 10,49 −194 041 5 761 044
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 567 762 3,37
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 066 549 262 −3,18 10,18 −183 903 5 591 213
2022-09-02 2022-09-01 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 567 328 5,83 2,48 77 500 1 406 973
2022-08-17 2022-08-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −5 751 536 078 −1,06 12,96 −74 533 6 947 571
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,45 −9 447
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,45 −9 448
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 9,44 −4 722
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 541 829 −3,30 9,45 −174 879 5 121 855
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 560 329 3,41
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 325 541 829 −3,27 9,53 −174 562 5 161 409
2022-08-05 2022-08-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 560 154 5,91 2,48 77 500 1 389 182
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,07 −9 068
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 9,07 −9 070
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 9,06 −4 531
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 528 904 −3,38 9,07 −167 745 4 795 731
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 547 404 3,50
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 614 528 904 −3,40 9,04 −168 233 4 780 234
2022-07-08 2022-07-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 547 518 6,05 2,48 77 500 1 357 845
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,34 −6 341
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,35 −6 346
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,34 −3 172
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 516 268 −3,46 6,34 −117 381 3 275 669
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 534 768 3,58
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −21 190 516 268 −3,94 5,87 −124 385 3 030 493
2022-06-06 2022-06-02 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 537 458 6,17 2,48 77 500 1 332 896
2022-05-18 2022-05-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes X −5 764 506 208 −1,13 5,67 −32 682 2 870 199
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 134 875 −0,74
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 134 875 −0,74
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 544 000 −0,09
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 806 834 −0,27
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,44 −6 439
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,43 −6 435
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,44 −3 221
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 511 972 −3,49 6,44 −119 118 3 296 485
2022-05-06 2022-05-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 530 472 3,61
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 135 875 −0,73
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 135 875 −0,73
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 544 500 −0,09
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −31 250 1 000 000 −3,03
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 825 334 −0,27
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,47 −6 474
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,48 −6 481
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,47 −3 235
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 511 972 −3,49 6,48 −119 852 3 316 811
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 530 472 3,61
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −13 330 511 972 −2,54 6,50 −86 645 3 327 818
2022-05-06 2022-05-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 31 250 525 302 6,33 2,48 77 500 1 302 749
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 136 875 −0,73
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 136 875 −0,73
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 545 000 −0,09
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 031 250 −4,09
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 843 834 −0,27
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,31 −6 308
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,30 −6 304
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,31 −3 156
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 494 052 −3,61 6,30 −116 576 3 113 219
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 512 552 3,74
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −19 570 494 052 −3,81 6,07 −118 757 2 998 056
2022-05-02 2022-04-29 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 014 513 622 9,37 2,48 109 155 1 273 783
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 137 875 −0,72
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 137 875 −0,72
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 545 500 −0,09
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 075 264 −3,93
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 862 334 −0,27
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,07 −6 070
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,07 −6 069
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,05 −3 026
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 469 608 −3,79 6,08 −112 545 2 856 860
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 488 108 3,94
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −19 105 469 608 −3,91 6,10 −116 571 2 865 360
2022-05-02 2022-04-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 488 713 9,90 2,48 109 145 1 212 008
2022-04-25 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Commo Stock
C - Conversion X −12 000 6 880 834 −0,17
2022-04-25 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
G - Gift X −12 000 444 703 −2,63
2022-04-25 2022-04-25 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 12 000 456 703 2,70
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 138 875 −0,71
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 138 875 −0,71
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 546 000 −0,09
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 119 274 −3,78
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 892 834 −0,27
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,00 −6 005
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,01 −6 006
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 5,99 −2 995
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 444 703 −3,99 6,00 −111 080 2 670 130
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 463 203 4,16
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −19 453 444 703 −4,19 6,07 −118 095 2 699 703
2022-04-25 2022-04-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 464 156 10,47 2,48 109 145 1 151 107
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 139 875 −0,71
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 139 875 −0,71
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 546 500 −0,09
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 163 284 −3,65
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 911 334 −0,27
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,18 −6 185
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,18 −6 184
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,19 −3 097
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 420 146 −4,22 6,19 −114 461 2 599 485
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 438 646 4,40
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 655 420 146 −4,25 6,44 −120 168 2 706 412
2022-04-25 2022-04-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 438 801 11,15 2,48 109 145 1 088 226
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 140 875 −0,70
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 140 875 −0,70
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 547 000 −0,09
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 207 294 −3,52
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 929 834 −0,27
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,71 −6 706
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,71 −6 706
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,72 −3 358
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 394 791 −4,48 6,70 −123 896 2 643 955
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 413 291 4,69
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −17 336 394 791 −4,21 6,99 −121 175 2 759 510
2022-04-20 2022-04-18 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 412 127 11,96 2,48 109 145 1 022 075
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 141 875 −0,70
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 141 875 −0,70
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 547 500 −0,09
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 251 304 −3,40
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 948 334 −0,27
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,51 −7 512
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,51 −7 505
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 7,50 −3 750
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 368 117 −4,79 7,51 −138 874 2 763 344
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 386 617 5,03
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −16 017 368 117 −4,17 7,62 −121 989 2 803 653
2022-04-18 2022-04-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 384 134 12,94 2,48 109 145 952 652
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 142 875 −0,70
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 142 875 −0,70
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 548 000 −0,09
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 295 314 −3,29
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 966 834 −0,26
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,71 −6 712
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,71 −6 712
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,69 −3 347
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 340 124 −5,16 6,72 −124 355 2 286 280
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 358 544 5,44
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 420 340 124 −5,14 6,45 −118 864 2 194 820
2022-04-12 2022-04-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 358 544 13,99 2,48 109 145 889 189
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 143 875 −0,69
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 143 875 −0,69
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 548 500 −0,09
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 339 324 −3,18
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 985 334 −0,26
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,52 −6 522
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,51 −6 512
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,50 −3 248
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 314 534 −5,55 6,53 −120 792 2 053 687
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 333 034 5,88
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 218 314 534 −5,47 6,56 −119 446 2 062 242
2022-04-11 2022-04-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 332 752 15,24 2,48 109 145 825 225
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 144 875 −0,69
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 144 875 −0,69
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 549 000 −0,09
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 383 334 −3,08
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 6 985 334 −0,26
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,56 −6 561
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 6,57 −6 568
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 6,55 −3 277
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 288 742 −6,02 6,56 −121 434 1 895 302
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 307 242 6,41
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −17 326 288 742 −5,66 7,00 −121 279 2 021 136
2022-04-08 2022-04-06 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 306 068 16,79 2,48 109 145 759 049
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 145 875 −0,68
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 000 145 875 −0,68
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −500 549 500 −0,09
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −44 010 1 427 344 −2,99
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −18 500 7 003 834 −0,26
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,31 −7 309
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 000 0 −100,00 7,31 −7 309
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 000 1 000
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −500 0 −100,00 7,33 −3 666
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 500 500
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −18 500 262 058 −6,59 7,31 −135 176 1 914 805
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 18 500 280 558 7,06
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −15 972 262 058 −5,74 7,58 −121 058 1 986 242
2022-04-07 2022-04-05 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 44 010 278 030 18,81 2,48 109 145 689 514
2022-03-15 2022-03-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −6 150 7 022 334 −0,09
2022-03-15 2022-03-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −6 150 234 020 −2,56 6,08 −37 407 1 423 427
2022-03-15 2022-03-15 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 6 150 240 170 2,63
2022-03-15 2022-03-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −230 000 7 028 484 −3,17
2022-03-15 2022-03-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −230 000 234 020 −49,57 6,28 −1 444 814 1 470 067
2022-03-15 2022-03-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 230 000 464 020 98,28
2022-03-15 2022-03-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −100 000 7 258 484 −1,36
2022-03-15 2022-03-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −100 000 234 020 −29,94 6,95 −694 580 1 625 456
2022-03-15 2022-03-11 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 100 000 334 020 42,73
2022-03-09 2022-03-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −300 000 7 358 484 −3,92
2022-03-09 2022-03-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −300 000 234 020 −56,18 7,30 −2 188 950 1 707 527
2022-03-09 2022-03-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 300 000 534 020 128,19
2022-02-24 2022-02-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −100 000 7 658 484 −1,29
2022-02-24 2022-02-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −100 000 234 020 −29,94 10,22 −1 021 540 2 390 608
2022-02-24 2022-02-22 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 100 000 334 020 42,73
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 5 436 5 436
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 416 350 416 350
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
F - Taxes −343 234 020 −0,15 11,40 −3 910 2 667 828
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 2 718 234 363 1,17
2022-02-08 2022-02-04 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
A - Award 208 175 231 645 886,98
2022-02-02 2022-01-31 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −19 858 7 758 484 −0,26
2022-02-02 2022-01-31 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −19 858 23 470 −45,83 11,73 −232 964 275 338
2022-02-02 2022-01-31 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 19 858 43 328 84,61
2022-01-14 2022-01-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −254 000 7 778 342 −3,16
2022-01-14 2022-01-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −254 000 23 470 −91,54 13,57 −3 445 612 318 380
2022-01-14 2022-01-14 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 254 000 277 470 1 082,23
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion −87 000 8 032 342 −1,07
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −8 794 23 470 −27,26 14,96 −131 575 351 156
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale −78 206 32 264 −70,79 14,26 −1 114 991 459 991
2022-01-14 2022-01-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion 87 000 110 470 370,69
2022-01-14 2021-12-28 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift −75 000 8 119 342 −0,92
2021-12-20 2021-12-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −200 8 194 342 0,00
2021-12-20 2021-12-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −200 23 470 −0,84 20,00 −4 001 469 517
2021-12-20 2021-12-16 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 200 23 670 0,85
2021-12-15 2021-12-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −100 8 194 542 0,00
2021-12-15 2021-12-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −100 23 470 −0,42 20,02 −2 002 469 752
2021-12-15 2021-12-13 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 100 23 570 0,43
2021-12-10 2021-12-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −1 086 8 194 642 −0,01
2021-12-10 2021-12-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −1 086 23 470 −4,42 20,01 −21 730 469 614
2021-12-10 2021-12-09 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 1 086 24 556 4,63
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
C - Conversion X −5 488 8 195 728 −0,07
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −28 646 1 471 354 −1,91
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −5 488 23 470 −18,95 20,26 −111 162 475 397
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
C - Conversion X 5 488 28 958 23,38
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
S - Sale X −5 176 23 470 −18,07 20,03 −103 670 470 081
2021-12-10 2021-12-08 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class A Common Stock
M - Exercise X 28 646 28 646 2,47 70 756 70 756
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X −100 146 875 −0,07 21,07 −2 107 3 094 656
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X −3 025 146 975 −2,02 20,49 −61 994 3 012 076
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X −1 200 8 201 216 −0,01 21,06 −25 267 172 683 164
2021-12-09 2021-12-07 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
S - Sale X −15 467 8 202 416 −0,19 20,43 −316 065 167 614 730
2021-12-09 2021-11-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift 550 000 550 000
2021-12-09 2021-11-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift 550 000 550 000
2021-12-09 2021-11-21 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
G - Gift −1 100 000 8 217 883 −11,81
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
C - Conversion 1 500 000 1 500 000
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
C - Conversion −1 500 000 0 −100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Series A-1 Preferred Stock
C - Conversion −32 685 0 −100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Serie A Preferred Stock
C - Conversion −22 698 0 −100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
J - Other 150 000 150 000
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
J - Other −150 000 0 −100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Class B Common Stock
J - Other 9 317 883 9 317 883
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
J - Other −9 317 883 0 −100,00
2021-04-22 2021-04-20 4 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
C - Conversion 55 383 9 317 883 0,60
2021-04-15 3 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
9 262 500
2021-04-15 3 RXRX RECURSION PHARMACEUTICALS, INC.
Common Stock
150 000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)